» Articles » PMID: 2053422

Trends in Mortality from Coronary Heart and Cerebrovascular Disease in Switzerland, 1969-87

Overview
Date 1991 Jan 1
PMID 2053422
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Trends in age-specific and age-standardized death certification rates from all ischaemic heart disease and cerebrovascular disease in Switzerland have been analysed for the period 1969-87, i.e. since the introduction of the Eighth Revision of the International Classification of Diseases for coding causes of death. For coronary heart disease, overall age-standardized rates of males in the mid-late 1980's were similar to those in the late 1960's, although some upward trend was evident up to the mid 1970's (with a peak rate of 120.4/100,000, World standard, in 1978) followed by steady declines in more recent years (103.8/100,000 in 1987). These falls were larger in truncated (35 to 64 years) rates. For females, overall age-standardized rates were stable around a value of 40/100,000, while truncated rates tended to decrease, particularly over most recent years, with an overall decline of over 25%. Examination of age-specific trends showed that in both sexes declines at younger ages were already evident in the earlier calendar period, while above age 50 some fall became evident only in most recent years. Thus, in a formal log-linear age/period/cohort model, both a period and a cohort component emerged. In relation to cerebrovascular diseases, the overall declines were around 40% in males (from 67.4 to 41.2/100,000, World standard) and 45% for females (from 56.6 to 31.7/100,000), and were proportionally comparable across subsequent age groups above age 45. The estimates for the age/period/cohort model were thus downwards both for the period and the cohort component although, in such a situation, it is difficult to disentangle the major underlying component.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Trends in coronary heart disease in two Belgian areas: results from the MONICA Ghent-Charleroi Study.

De Henauw S, De Bacquer D, de Smet P, Kornitzer M, De Backer G J Epidemiol Community Health. 1999; 53(2):89-98.

PMID: 10396469 PMC: 1756828. DOI: 10.1136/jech.53.2.89.


[Incidence of use of various myocardial infarct treatments in 2 Swiss regions].

Gothuey J, Wietlisbach V, Rickenbach M, Barazzoni F, La Vecchia C Soz Praventivmed. 1991; 36(6):333-40.

PMID: 1684884 DOI: 10.1007/BF01368741.

References
1.
Kushi L, Lew R, STARE F, Ellison C, el Lozy M, Bourke G . Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl J Med. 1985; 312(13):811-8. DOI: 10.1056/NEJM198503283121302. View

2.
Paccaud F . Analysing trends in cardiovascular mortality: some methodological points. Soz Praventivmed. 1984; 29(6):253-7. DOI: 10.1007/BF02078260. View

3.
. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986; 2(8498):57-66. View

4.
EPSTEIN F . The relationship of lifestyle to international trends in CHD. Int J Epidemiol. 1989; 18(3 Suppl 1):S203-9. View

5.
Osmond C, Gardner M . Age, period and cohort models applied to cancer mortality rates. Stat Med. 1982; 1(3):245-59. DOI: 10.1002/sim.4780010306. View